- Home
- VINP vs PHAR Comparison
VINP vs PHAR Comparison
Compare VINP & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VINP
- PHAR
- Stock Information
- Founded
- VINP 2009
- PHAR 1988
- Country
- VINP Brazil
- PHAR Netherlands
- Employees
- VINP N/A
- PHAR N/A
- Industry
- VINP Investment Managers
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- VINP Finance
- PHAR Health Care
- Exchange
- VINP Nasdaq
- PHAR Nasdaq
- Market Cap
- VINP 641.7M
- PHAR 627.5M
- IPO Year
- VINP 2021
- PHAR N/A
- Fundamental
- Price
- VINP $9.76
- PHAR $9.98
- Analyst Decision
- VINP Strong Buy
- PHAR Strong Buy
- Analyst Count
- VINP 2
- PHAR 3
- Target Price
- VINP $13.50
- PHAR $27.00
- AVG Volume (30 Days)
- VINP 95.1K
- PHAR 6.0K
- Earning Date
- VINP 02-05-2025
- PHAR 03-13-2025
- Dividend Yield
- VINP 5.53%
- PHAR N/A
- EPS Growth
- VINP N/A
- PHAR N/A
- EPS
- VINP 0.60
- PHAR N/A
- Revenue
- VINP $88,217,697.00
- PHAR $285,745,000.00
- Revenue This Year
- VINP $17.23
- PHAR $20.08
- Revenue Next Year
- VINP $51.06
- PHAR $9.22
- P/E Ratio
- VINP $16.31
- PHAR N/A
- Revenue Growth
- VINP 9.03
- PHAR 30.64
- 52 Week Low
- VINP $9.01
- PHAR $6.65
- 52 Week High
- VINP $11.85
- PHAR $13.20
- Technical
- Relative Strength Index (RSI)
- VINP 45.56
- PHAR 56.13
- Support Level
- VINP $9.19
- PHAR $9.37
- Resistance Level
- VINP $10.14
- PHAR $10.15
- Average True Range (ATR)
- VINP 0.24
- PHAR 0.50
- MACD
- VINP -0.00
- PHAR -0.09
- Stochastic Oscillator
- VINP 60.00
- PHAR 57.53
About VINP Vinci Partners Investments Ltd.
Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Market; Liquid Strategies; Investment Products and solutions; Financial Advisory; and Retirement Services. The company's majority of its revenue comes from the Private Market segment which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.